118 related articles for article (PubMed ID: 7905027)
1. Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease.
Ichai C; Chevallier N; Delaere P; Dournaud P; Epelbaum J; Hauw JJ; Vincent JP; Checler F
J Neurochem; 1994 Feb; 62(2):645-55. PubMed ID: 7905027
[TBL] [Abstract][Full Text] [Related]
2. Alterations of peptide metabolism and neuropeptidase activity in senile dementia of the Alzheimer's type.
Waters SM; Davis TP
Ann N Y Acad Sci; 1997 Apr; 814():30-9. PubMed ID: 9160957
[TBL] [Abstract][Full Text] [Related]
3. Metabolic half-life of somatostatin and peptidase activities are altered in Alzheimer's disease.
Weber SJ; Louis RB; Trombley L; Bissette G; Davies P; Davis TP
J Gerontol; 1992 Jan; 47(1):B18-25. PubMed ID: 1346149
[TBL] [Abstract][Full Text] [Related]
4. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes.
Mentlein R; Dahms P
J Neurochem; 1994 Jan; 62(1):27-36. PubMed ID: 7903352
[TBL] [Abstract][Full Text] [Related]
5. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.
Quirion R; Martel JC; Robitaille Y; Etienne P; Wood P; Nair NP; Gauthier S
Can J Neurol Sci; 1986 Nov; 13(4 Suppl):503-10. PubMed ID: 2878714
[TBL] [Abstract][Full Text] [Related]
6. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
Kowall NW; Beal MF
Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
[TBL] [Abstract][Full Text] [Related]
7. Differential catabolic fate of neuromedin N and neurotensin in the canine intestinal mucosa.
Barelli H; Mao YK; Vincent B; Daniel EE; Vincent JP; Checler F
Peptides; 1993; 14(3):457-63. PubMed ID: 8332546
[TBL] [Abstract][Full Text] [Related]
8. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
Davies P; Katzman R; Terry RD
Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
[TBL] [Abstract][Full Text] [Related]
9. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin- and neuropeptide Y-immunoreactive neurons in the neocortex in senile dementia of Alzheimer's type.
Nakamura S; Vincent SR
Brain Res; 1986 Apr; 370(1):11-20. PubMed ID: 2871890
[TBL] [Abstract][Full Text] [Related]
11. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
Chalmers DT; Dewar D; Graham DI; Brooks DN; McCulloch J
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1352-6. PubMed ID: 2154742
[TBL] [Abstract][Full Text] [Related]
12. Subpopulations of somatostatin 28-immunoreactive neurons display different vulnerability in senile dementia of the Alzheimer type.
Gaspar P; Duyckaerts C; Febvret A; Benoit R; Beck B; Berger B
Brain Res; 1989 Jun; 490(1):1-13. PubMed ID: 2569349
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.
Engber TM; Boldry RC; Kuo S; Chase TN
Brain Res; 1992 May; 581(2):261-8. PubMed ID: 1356580
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin and neuromedin N undergo distinct catabolic processes in murine astrocytes and primary cultured neurons.
Vincent B; Vincent JP; Checler F
Eur J Biochem; 1994 Apr; 221(1):297-306. PubMed ID: 7909519
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide-hydrolysing activities in synaptosomal fractions from dog ileum myenteric, deep muscular and submucous plexi. Their participation in neurotensin inactivation.
Barelli H; Ahmad S; Kostka P; Fox JA; Daniel EE; Vincent JP; Checler F
Peptides; 1989; 10(5):1055-61. PubMed ID: 2575247
[TBL] [Abstract][Full Text] [Related]
16. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
Crystal HA; Davies P
J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
[TBL] [Abstract][Full Text] [Related]
17. Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease.
Sherif F; Gottfries CG; Alafuzoff I; Oreland L
J Neural Transm Park Dis Dement Sect; 1992; 4(3):227-40. PubMed ID: 1627256
[TBL] [Abstract][Full Text] [Related]
18. A survey of the cerebral regionalization and ontogeny of eight exo- and endopeptidases in murines.
Dauch P; Masuo Y; Vincent JP; Checler F
Peptides; 1993; 14(3):593-9. PubMed ID: 8332554
[TBL] [Abstract][Full Text] [Related]
19. Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease.
Waters SM; David TP
J Gerontol A Biol Sci Med Sci; 1995 Sep; 50(5):B315-9. PubMed ID: 7545530
[TBL] [Abstract][Full Text] [Related]
20. A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease.
Davies CA; Morroll DR; Prinja D; Mann DM; Gibbs A
J Neurol Sci; 1990 Apr; 96(1):59-73. PubMed ID: 1972185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
